Catalyst and Walgreen Co. Announce Early Termination of Hart-Scott-Rodino Act Waiting Period

ROCKVILLE, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Catalyst Health Solutions, Inc. (NASDAQ:CHSI) and Walgreen Co. (NYSE, NASDAQ: WAG) announced that the Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Catalyst’s previously announced proposed acquisition of Walgreens Health Initiatives, Inc., the pharmacy benefit management subsidiary of Walgreen Co.